46 results
Page 2 of 3
6-K
n2j o0hjohd
28 Apr 22
Current report (foreign)
4:06pm
6-K
EX-99.3
5usn5queshzwkg q74
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.3
mb5pkz
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.11
yjpa4wxuxdeggf
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.2
5j6 ar6s43j0
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.1
o32dq fhva6
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
g5hmgbdc
27 Jan 22
Galapagos appoints Paul Stoffels as Chief Executive Officer
12:00am
6-K
EX-99.1
k9424z 4p2na8q
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.2
v1oqozyi
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
r3tpkuvh3d4
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
gzpa08no4c
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
k8j5b4f959wju1orfm9
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
45lqhyvovfk7grprd
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
424B5
68v u491xm
13 Sep 18
Prospectus supplement for primary offering
12:00am
424B5
ilry2d dktly
18 Apr 17
Prospectus supplement for primary offering
12:00am